GENTAUR Europe BVBA
Genprice Inc, Logistics
Serbia, 
Macedonia, 
Montenegro, 
Croatia: 
GENTAUR Romania
GENTAUR Greece 
A blood test can be used to identify patients in whom skin cancer spreads to other organs, according to a presentation given at a conference at National Cancer Research Institute in the UK.
The presence of metastases of melanoma - the most dangerous and aggressive skin cancer, is one of the biggest challenges in medicine. According to researchers from the University of Dundee measurement of gene TFP12 may be the key to faster diagnosis and a new treatment.
This may be achieved by using a single blood test. If doctors know when the tumor begins to affect other organs, the chances for a cure are much higher, said the head of research - Dr Tim Crook.
Researchers to reach the conclusion that "exclusion" and "inclusion" of certain genes may affect how, where and why spreading melanoma. The next step for researchers to develop a panel of biomarkers such, by means of which will be able to detect those patients who are in need of further treatment in the fight against melanoma.
The research team identified other biomarker - NT5E, which is associated with the spread of aggressive melanoma. Experts believe that based on the findings will be possible to develop a new treatment for the disease.
